agilon health, inc. Amortization of Intangible Assets
agilon health, inc. (AGL) reported Amortization of Intangible Assets of $13.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-25
- agilon health, inc. amortization of intangible assets for the quarter ending 2025-12-31 was $3.30M, a 3.13% increase year-over-year.
- agilon health, inc. amortization of intangible assets for the quarter ending 2025-09-30 was $3.60M, a 16.13% increase year-over-year.
- agilon health, inc. amortization of intangible assets for the quarter ending 2025-06-30 was $3.40M, a 13.33% increase year-over-year.
- agilon health, inc. amortization of intangible assets for the quarter ending 2025-03-31 was $3.10M, a 6.90% increase year-over-year.
- agilon health, inc. amortization of intangible assets for fiscal 2025 was $13.40M, a 8.94% increase from fiscal 2024.
- agilon health, inc. amortization of intangible assets for fiscal 2024 was $12.30M, a 53.75% increase from fiscal 2023.
- agilon health, inc. amortization of intangible assets for fiscal 2023 was $8.00M, a 60.00% increase from fiscal 2022.
- agilon health, inc. amortization of intangible assets for fiscal 2022 was $5.00M, a 39.02% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.90M derived: sum of 2 quarters · filed 2026-02-25 | $10.30M derived: sum of 3 quarters · filed 2026-02-25 | $13.40M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $3.60M 10-Q · filed 2025-11-04 | $7.00M derived: sum of 2 quarters · filed 2025-11-04 | $10.10M 10-Q · filed 2025-11-04 | $13.30M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2025-06-30 | $3.40M 10-Q · filed 2025-08-04 | $6.50M 10-Q · filed 2025-08-04 | $9.70M derived: sum of 3 quarters · filed 2026-02-25 | $12.80M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2025-03-31 | $3.10M 10-Q · filed 2025-05-06 | $6.30M derived: sum of 2 quarters · filed 2026-02-25 | $9.40M derived: sum of 3 quarters · filed 2026-02-25 | $12.40M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.30M derived: sum of 2 quarters · filed 2026-02-25 | $9.30M derived: sum of 3 quarters · filed 2026-02-25 | $12.30M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $3.10M 10-Q · filed 2025-11-04 | $6.10M derived: sum of 2 quarters · filed 2025-11-04 | $9.10M 10-Q · filed 2025-11-04 | $11.30M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $3.00M 10-Q · filed 2025-08-04 | $6.00M 10-Q · filed 2025-08-04 | $8.20M derived: sum of 3 quarters · filed 2026-02-25 | $10.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $2.90M 10-Q · filed 2025-05-06 | $5.20M derived: sum of 2 quarters · filed 2026-02-25 | $7.20M derived: sum of 3 quarters · filed 2026-02-25 | $9.70M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.30M derived: sum of 2 quarters · filed 2026-02-25 | $6.80M derived: sum of 3 quarters · filed 2026-02-25 | $8.00M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $2.00M 10-Q · filed 2024-11-07 | $3.20M 10-Q · filed 2023-11-02 | $4.50M derived: sum of 2 quarters · filed 2024-11-07 | $5.70M 10-Q · filed 2024-11-07 | $9.40M 10-Q · filed 2023-11-02 | $3.60M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | $2.50M 10-Q · filed 2024-08-06 | $3.70M 10-Q · filed 2023-08-03 | $3.70M 10-Q · filed 2024-08-06 | $6.20M 10-Q · filed 2023-08-03 | $1.60M derived: sum of 3 quarters · filed 2025-02-25 | $3.70M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $1.30M 10-Q · filed 2024-05-07 | $2.50M 10-Q · filed 2023-05-09 | -$900.00K derived: sum of 2 quarters · filed 2025-02-25 | $1.20M derived: sum of 3 quarters · filed 2025-02-25 | $3.60M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$100.00K derived: sum of 2 quarters · filed 2025-02-25 | $2.30M derived: sum of 3 quarters · filed 2025-02-25 | $5.00M 10-K · filed 2025-02-25 | $9.70M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $2.10M 10-Q · filed 2023-11-02 | $4.50M derived: sum of 2 quarters · filed 2023-11-02 | $7.20M 10-Q · filed 2023-11-02 | $6.30M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $2.40M 10-Q · filed 2023-08-03 | $5.10M 10-Q · filed 2023-08-03 | $4.20M derived: sum of 3 quarters · filed 2024-02-27 | $7.50M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | $2.70M 10-Q · filed 2023-05-09 | $1.80M derived: sum of 2 quarters · filed 2024-02-27 | $5.10M derived: sum of 3 quarters · filed 2024-02-27 | $8.10M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $2.40M derived: sum of 2 quarters · filed 2024-02-27 | $5.40M derived: sum of 3 quarters · filed 2024-02-27 | $8.20M 10-K · filed 2024-02-27 | $11.90M 10-K · filed 2022-03-03 | |||
| 2021-09-30 | $3.30M 10-Q · filed 2022-11-03 | $6.30M derived: sum of 2 quarters · filed 2022-11-03 | $9.10M 10-Q · filed 2022-11-03 | $12.20M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $3.00M 10-Q · filed 2022-08-04 | $5.80M 10-Q · filed 2022-08-04 | $8.90M derived: sum of 3 quarters · filed 2023-03-01 | $11.70M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $2.80M 10-Q · filed 2022-05-05 | $5.90M derived: sum of 2 quarters · filed 2023-03-01 | $8.70M derived: sum of 3 quarters · filed 2023-03-01 | $11.50M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $5.90M derived: sum of 2 quarters · filed 2023-03-01 | $8.70M derived: sum of 3 quarters · filed 2023-03-01 | $11.40M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $2.80M 10-Q · filed 2021-10-28 | $5.60M derived: sum of 2 quarters · filed 2021-10-28 | $8.30M 10-Q · filed 2021-10-28 | |||||
| 2020-06-30 | $2.80M 10-Q · filed 2021-08-04 | $5.50M 10-Q · filed 2021-08-04 | ||||||
| 2020-03-31 | $2.70M 10-Q · filed 2021-05-26 | |||||||
| 2019-12-31 | $10.70M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |